SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-071065
Filing Date
2023-12-18
Accepted
2023-12-18 16:00:10
Documents
15
Period of Report
2023-12-15
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnlx-20231215.htm   iXBRL 8-K 40497
2 EX-99.1 rnlx-ex99_1.htm EX-99.1 20412
3 GRAPHIC img102423453_0.jpg GRAPHIC 28770
  Complete submission text file 0000950170-23-071065.txt   266764

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnlx-20231215_def.xml EX-101.DEF 15111
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnlx-20231215.xsd EX-101.SCH 3146
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnlx-20231215_lab.xml EX-101.LAB 20218
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnlx-20231215_pre.xml EX-101.PRE 15280
9 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20231215_htm.xml XML 6073
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 231493635
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)